The Biotechnology Venture Capital Best Practices Conference - The Worlds Top VCs on Valuations, Exit Strategies and Investment Practices (Reedlogic Conference)

The Biotechnology Venture Capital Best Practices Conference features eight speeches totaling more than three hours of authoritative, insiders perspectives on the best practices of the worlds top biotechnology venture capital firms. Featuring managing and venture partners from some of the nation's top companies, this conference provides a broad yet comprehensive overview of the biotechnology venture capital world, presenting to attendees superior venture capital strategies. Each speaker shares their insight for thriving business practices and industry expertise in a format similar to a radio address, with graphics displayed in the background. Simply insert the CD-ROM into your computer, sit back, and watch and learn from the top professionals in the field as they discuss their specific strategies for valuating companies, attaining exit strategies, and ensuring success. The breadth of perspectives presented enable attendees to get inside some of the great minds of the biotechnology venture capital world without leaving the office. The conference has been produced on CD-ROM and can be viewed in PowerPoint by any PC-based computer. The conference features speeches by: 1- William Kieger, President and Founder, Aurora Capital Developing Products with Commercial Value. 2- Andrew D. Clapp, Partner, Brook Venture Partners Focusing on the Probability of Every Investment being Sucessful. 3- John Pacifico, Investment Analyst, Canaan Partners Identifying the Opportunity for the Company and the Management Team. 4- Martin E. Sanders, Partner, Charter Life Sciences Finding Companies with Product Focus. 5- William L. Robbins, Managing Director, Convergent Ventures Early Stage Investing. 6- Charles Hsu, Partner, A.M. Pappas & Associates Foreign Impact on the Biotechnology Sector. 7- Fritz R. Buhler, Director, Bear Stearns Health Innoventures, L.P. What Defines the Value of a Company. 8- Peter Allison, Partner, BioGenesis Investments Providing Clients with All the Information. In this CD-ROM you will learn: How to make successful investments in Biotechnology VC. The biggest factors in establishing a Biotechnology VC valuation. How valuations change with different funding rounds. The Top 5 things an entrepreneur can do to increase their chances for a higher valuation The best time to pursue an exit strategy in Biotech VC.